1. Home
  2. MBOT vs CCIF Comparison

MBOT vs CCIF Comparison

Compare MBOT & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • CCIF
  • Stock Information
  • Founded
  • MBOT 2010
  • CCIF 2011
  • Country
  • MBOT United States
  • CCIF United States
  • Employees
  • MBOT N/A
  • CCIF N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • CCIF Finance/Investors Services
  • Sector
  • MBOT Health Care
  • CCIF Finance
  • Exchange
  • MBOT Nasdaq
  • CCIF Nasdaq
  • Market Cap
  • MBOT 128.9M
  • CCIF 110.4M
  • IPO Year
  • MBOT N/A
  • CCIF N/A
  • Fundamental
  • Price
  • MBOT $1.91
  • CCIF $5.17
  • Analyst Decision
  • MBOT Strong Buy
  • CCIF
  • Analyst Count
  • MBOT 1
  • CCIF 0
  • Target Price
  • MBOT $12.00
  • CCIF N/A
  • AVG Volume (30 Days)
  • MBOT 1.9M
  • CCIF 76.9K
  • Earning Date
  • MBOT 11-12-2025
  • CCIF 01-01-0001
  • Dividend Yield
  • MBOT N/A
  • CCIF 25.90%
  • EPS Growth
  • MBOT N/A
  • CCIF N/A
  • EPS
  • MBOT N/A
  • CCIF N/A
  • Revenue
  • MBOT N/A
  • CCIF N/A
  • Revenue This Year
  • MBOT N/A
  • CCIF N/A
  • Revenue Next Year
  • MBOT $1,107.73
  • CCIF N/A
  • P/E Ratio
  • MBOT N/A
  • CCIF N/A
  • Revenue Growth
  • MBOT N/A
  • CCIF N/A
  • 52 Week Low
  • MBOT $0.93
  • CCIF $7.43
  • 52 Week High
  • MBOT $4.67
  • CCIF $10.16
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 36.04
  • CCIF 46.23
  • Support Level
  • MBOT $1.70
  • CCIF $4.69
  • Resistance Level
  • MBOT $2.20
  • CCIF $5.27
  • Average True Range (ATR)
  • MBOT 0.13
  • CCIF 0.13
  • MACD
  • MBOT 0.02
  • CCIF 0.01
  • Stochastic Oscillator
  • MBOT 40.40
  • CCIF 70.70

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.

About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest

Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: